Dendreon Raises $197M in Stock Offering
Biotech cancer FinancesLuke Timmerman wrote:Dendreon raised $197.4 million in the offering it announced last week according to a regulatory filing. The Seattle biotech company (NASDAQ: DNDN) sold 10.7 million shares of stock at $18.45 apiece last Thursday about a 15 percent discount on the clos ...

Stock MArket - Trading Earnings: WebMD Health Corp. (WBMD) Is There A Doctor In The House?
Wow May was another great month for the S&P 500 UP 9.98%. As hot as the S&P 500’s performance was our 6 Stocks For April performance knocked out the index; putting a stunning 14.67% return in our subscriber’s pockets. That’s on the heels of 15.68% profit in March for a whopping 30.35% in ...


Dendreon Day - What Got People More Excited the Announcement or the Stock?
A current treatment docetaxel (Taxotere) has some pretty bad side effects but Provenge can extend life without the nasty chemo effects.  What was a bit of a big sideline today was watching the stock it was a real roller coaster questioned and verified by Nasdaq.  The Wall Street Journal has ...

After Yesterday’s Storm Sun Shines Again on Dendreon’s Shares
Dendreon’s gyrations continue: The biotech company’s shares surged this morning after a sudden plunge yesterday as Dendreon was to about to announce details of its latest Provenge study.The share price more than doubled to $25.42 in morning trading. This comes after the shares’ roller-coa ...

Staples: Rewards for patient investors
Filed under: Newsletters Staples Inc (SPLS) Stocks to Buy"I've always liked Staples (NASDAQ: SPLS); the company has traditionally put up good numbers and the stock price has been rewarding for investors over the years" says Chuck Carlson noting "Staples is the world's largest office products co ...